Genfleet Therapeutics (Shanghai), Inc. Class H ( (HK:2595) ) just unveiled an announcement.

Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is ...

Summary • Erasca, Inc. (ERAS) shares rose 14.1% to $3.30 amid conference participation.• The company is attending the Evercore Healthcare Conference to discuss RAS/MAPK therapy advancements.• Analysts ...

Plexiform neurofibromas (PNF) are benign, often infiltrative tumours of the peripheral nerve sheath classically linked to ...

A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has ...

Erasca, Inc. (NASDAQ:ERAS) is one of the 12 hot penny stocks to invest in right now. On November 14, 2025, Erasca, Inc.

In this piece, we will discuss the 12 hot penny stocks to invest in right now. Amid an uncertain macro environment, where the economic outlook is blurry, the momentum of penny stocks depends heavily ...

A live audio webcast of the event will be available online at Erasca.com/events. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.

Gene Holdings Inc. , a clinical-stage, non-viral genetic medicines company, today announced that Alex Nichols, Ph.D., Chief Strategy and Operations Officer, will present at the Piper Sandler 37th ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Keysight shares surged 14.8% to $204.00 in the pre-market trading session. Here are some other stocks moving in pre-market ...

Zero Treatment Related Adverse Events observed during Cohort 7 (37mg capsules) DLT period – --Cohort 7 Pharmacokinetic (PK) ...